Online Resource Center


Fair Hearings
OTDA Policy
Language Resources
  Agency Directives:  Not Logged in     
Search Keywords or type in your question (min 3 char.)
PB Home  Back to OMM/OCFS/OTDA Materials: INFs Issued by OTDA    
Attached Document:

OMM/OCFS/OTDA Materials: INFs Issued by OTDA

90 INF-36: Medicaid Reimbursement of AZT for Foster Children
Recently the federal Food and Drug Administration approved the drug Retrovir (referred to as AZT) for use in the clinical treatment of children aged thirteen years or younger with HIV (Human Immuno-deficiency
Virus) infection. The purpose of this release is to inform local
departments of social services of the Department's policy regarding
reimbursement for the cost of AZT.


Created: 10/29/2004
Updated: 11/1/2004